Search

Thalmann GN

Stroma transcriptomic and proteomic profile of prostate cancer metastasis xenograft models reveals conservation of bone microenvironment signatures
Patient-derived xenografts and organoids model therapy response in prostate cancer
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification
miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo
Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer
Metastases in Prostate Cancer
Emerging aspects of microRNA interaction with TMPRSS2-ERG and endocrine therapy
ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models